We extend our in vitro findings to demonstrate that CD4 and CD8 T cells show increased baseline Th17 differentiation in CLL patients with early fulminant autoimmune toxicity compared to those without toxicity, and even compared to those with more delayed toxicity. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.